Dr. Reddy's Laboratories Limited (RDY)
USD 14.55
(0.48%)
USD 14.55
(0.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 106.96 Billion INR | 18.87% |
| 2023 | 89.99 Billion INR | -15.21% |
| 2022 | 106.12 Billion INR | 17.25% |
| 2021 | 90.51 Billion INR | 17.16% |
| 2020 | 77.25 Billion INR | -9.36% |
| 2019 | 85.23 Billion INR | -14.03% |
| 2018 | 99.14 Billion INR | 3.52% |
| 2017 | 95.77 Billion INR | 20.76% |
| 2016 | 79.31 Billion INR | -4.97% |
| 2015 | 83.46 Billion INR | 5.08% |
| 2014 | 79.42 Billion INR | -88.53% |
| 2013 | 692.64 Billion INR | 1016.58% |
| 2012 | 62.03 Billion INR | 26.56% |
| 2011 | 49.01 Billion INR | 31.0% |
| 2010 | 37.41 Billion INR | -10.38% |
| 2009 | 41.74 Billion INR | 8.78% |
| 2008 | 38.37 Billion INR | -13.63% |
| 2007 | 44.43 Billion INR | -4.68% |
| 2006 | 46.61 Billion INR | 459.27% |
| 2005 | 8.33 Billion INR | 49.05% |
| 2004 | 5.59 Billion INR | 31.65% |
| 2003 | 4.24 Billion INR | 21.16% |
| 2002 | 3.5 Billion INR | -46.9% |
| 2001 | 6.6 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 55.36 Billion INR | -38.48% |
| 2024 Q3 | 104.99 Billion INR | 11.77% |
| 2024 FY | 106.96 Billion INR | 18.87% |
| 2024 Q4 | 106.96 Billion INR | 1.88% |
| 2024 Q2 | 93.93 Billion INR | 69.67% |
| 2023 Q3 | 52.04 Billion INR | -38.59% |
| 2023 Q1 | 95.58 Billion INR | -9.93% |
| 2023 FY | 89.99 Billion INR | -15.21% |
| 2023 Q4 | 89.99 Billion INR | 72.9% |
| 2023 Q2 | 84.74 Billion INR | -11.34% |
| 2022 Q1 | 100.1 Billion INR | 10.6% |
| 2022 FY | 106.12 Billion INR | 17.25% |
| 2022 Q2 | 94.57 Billion INR | -5.52% |
| 2022 Q4 | 106.12 Billion INR | 14.75% |
| 2022 Q3 | 92.48 Billion INR | -2.21% |
| 2021 Q2 | 88.04 Billion INR | -1.63% |
| 2021 FY | 90.51 Billion INR | 17.16% |
| 2021 Q1 | 89.49 Billion INR | 15.85% |
| 2021 Q4 | 90.51 Billion INR | 9.11% |
| 2021 Q3 | 82.95 Billion INR | -5.78% |
| 2020 Q1 | 80.88 Billion INR | -5.1% |
| 2020 FY | 77.25 Billion INR | -9.36% |
| 2020 Q4 | 77.25 Billion INR | 11.6% |
| 2020 Q3 | 69.22 Billion INR | -13.52% |
| 2020 Q2 | 80.04 Billion INR | -1.03% |
| 2019 Q3 | 90.96 Billion INR | -11.5% |
| 2019 FY | 85.23 Billion INR | -14.03% |
| 2019 Q1 | 100.45 Billion INR | 1.32% |
| 2019 Q2 | 102.78 Billion INR | 2.33% |
| 2019 Q4 | 85.23 Billion INR | -6.31% |
| 2018 Q3 | 102.27 Billion INR | 2.09% |
| 2018 FY | 99.14 Billion INR | 3.52% |
| 2018 Q1 | 94.96 Billion INR | -0.85% |
| 2018 Q2 | 100.17 Billion INR | 5.49% |
| 2018 Q4 | 99.14 Billion INR | -3.06% |
| 2017 FY | 95.77 Billion INR | 20.76% |
| 2017 Q4 | 95.77 Billion INR | -9.77% |
| 2017 Q3 | 106.14 Billion INR | 0.95% |
| 2017 Q2 | 105.15 Billion INR | 29.16% |
| 2017 Q1 | 81.41 Billion INR | 2.65% |
| 2016 Q4 | 79.31 Billion INR | 0.14% |
| 2016 FY | 79.31 Billion INR | -4.97% |
| 2016 Q2 | 80.98 Billion INR | -1.61% |
| 2016 Q3 | 79.2 Billion INR | -2.21% |
| 2016 Q1 | 82.31 Billion INR | -1.37% |
| 2015 Q3 | 79.29 Billion INR | 2.56% |
| 2015 Q2 | 77.31 Billion INR | 0.65% |
| 2015 Q4 | 83.46 Billion INR | 5.26% |
| 2015 Q1 | 76.81 Billion INR | -3.28% |
| 2015 FY | 83.46 Billion INR | 5.08% |
| 2014 FY | 79.42 Billion INR | -88.53% |
| 2014 Q1 | 75.88 Billion INR | -89.04% |
| 2014 Q2 | 83.06 Billion INR | 9.46% |
| 2014 Q3 | 82.95 Billion INR | -0.13% |
| 2014 Q4 | 79.42 Billion INR | -4.25% |
| 2013 Q2 | 67.34 Billion INR | 0.56% |
| 2013 FY | 692.64 Billion INR | 1016.58% |
| 2013 Q4 | 692.64 Billion INR | 889.18% |
| 2013 Q3 | 70.02 Billion INR | 3.98% |
| 2013 Q1 | 66.97 Billion INR | 7.96% |
| 2012 Q3 | 70.5 Billion INR | 18.05% |
| 2012 Q1 | 49.04 Billion INR | 0.07% |
| 2012 FY | 62.03 Billion INR | 26.56% |
| 2012 Q4 | 62.03 Billion INR | -12.01% |
| 2012 Q2 | 59.72 Billion INR | 21.76% |
| 2011 Q2 | 38.12 Billion INR | 3.32% |
| 2011 FY | 49.01 Billion INR | 31.0% |
| 2011 Q1 | 36.89 Billion INR | -1.38% |
| 2011 Q4 | 49.01 Billion INR | 36.65% |
| 2011 Q3 | 35.87 Billion INR | -5.91% |
| 2010 Q4 | 37.41 Billion INR | 16.62% |
| 2010 Q1 | 31.39 Billion INR | -24.79% |
| 2010 Q2 | 37.02 Billion INR | 17.94% |
| 2010 Q3 | 32.08 Billion INR | -13.35% |
| 2010 FY | 37.41 Billion INR | -10.38% |
| 2009 Q1 | 41.7 Billion INR | 8.66% |
| 2009 Q2 | 45.87 Billion INR | 10.01% |
| 2009 FY | 41.74 Billion INR | 8.78% |
| 2009 Q4 | 41.74 Billion INR | -6.17% |
| 2009 Q3 | 44.49 Billion INR | -3.02% |
| 2008 Q3 | 35.21 Billion INR | -1.0% |
| 2008 Q2 | 35.56 Billion INR | 1.12% |
| 2008 Q1 | 35.17 Billion INR | -20.85% |
| 2008 FY | 38.37 Billion INR | -13.63% |
| 2008 Q4 | 38.37 Billion INR | 8.99% |
| 2007 Q2 | 56.36 Billion INR | 5.28% |
| 2007 Q3 | 48.53 Billion INR | -13.89% |
| 2007 Q4 | 44.43 Billion INR | -8.45% |
| 2007 FY | 44.43 Billion INR | -4.68% |
| 2007 Q1 | 53.53 Billion INR | 14.85% |
| 2006 Q1 | 9.6 Billion INR | 15.25% |
| 2006 Q3 | 10.33 Billion INR | 5.09% |
| 2006 Q2 | 9.83 Billion INR | 2.43% |
| 2006 Q4 | 46.61 Billion INR | 350.85% |
| 2006 FY | 46.61 Billion INR | 459.27% |
| 2005 Q1 | 7.88 Billion INR | 40.93% |
| 2005 FY | 8.33 Billion INR | 49.05% |
| 2005 Q2 | 6.57 Billion INR | -16.53% |
| 2005 Q3 | 6.31 Billion INR | -4.0% |
| 2005 Q4 | 8.33 Billion INR | 31.99% |
| 2004 Q3 | 4.82 Billion INR | -2.76% |
| 2004 Q4 | 5.59 Billion INR | 15.89% |
| 2004 Q2 | 4.96 Billion INR | 7.8% |
| 2004 FY | 5.59 Billion INR | 31.65% |
| 2004 Q1 | 4.6 Billion INR | 8.38% |
| 2003 FY | 4.24 Billion INR | 21.16% |
| 2003 Q2 | 3.91 Billion INR | -6.16% |
| 2003 Q1 | 4.17 Billion INR | 19.11% |
| 2003 Q4 | 4.24 Billion INR | 4.47% |
| 2003 Q3 | 4.06 Billion INR | 3.76% |
| 2002 Q1 | 3.83 Billion INR | 0.0% |
| 2002 FY | 3.5 Billion INR | -46.9% |
| 2002 Q2 | 3.56 Billion INR | -6.96% |
| 2002 Q3 | 3.54 Billion INR | -0.71% |
| 2002 Q4 | 3.5 Billion INR | -0.98% |
| 2001 FY | 6.6 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.45 Billion USD | -2998.225% |
| Bausch Health Companies Inc. | 27.43 Billion USD | -289.939% |
| Catalent, Inc. | 6.14 Billion USD | -1639.6% |
| Emergent BioSolutions Inc. | 1.18 Billion USD | -8922.267% |
| Elanco Animal Health Incorporated | 8.13 Billion USD | -1214.265% |
| Perrigo Company plc | 6.04 Billion USD | -1670.642% |
| Teva Pharmaceutical Industries Limited | 35.35 Billion USD | -202.571% |
| Zoetis Inc. | 9.29 Billion USD | -1050.812% |